Sökning: WFRF:(Morhed Elisabeth) > Stereotactic body r...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08380naa a2201129 4500 | |
001 | oai:gup.ub.gu.se/100357 | |
003 | SwePub | |
008 | 240910s2008 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:708e5202-accf-49d1-9db8-85f6186a02b2 | |
009 | oai:DiVA.org:uu-105474 | |
009 | oai:prod.swepub.kib.ki.se:117783253 | |
009 | oai:DiVA.org:liu-50265 | |
024 | 7 | a https://gup.ub.gu.se/publication/1003572 URI |
024 | 7 | a https://doi.org/10.1016/j.radonc.2008.07.0192 DOI |
024 | 7 | a https://lup.lub.lu.se/record/12841302 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1054742 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1177832532 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-502652 URI |
040 | a (SwePub)gud (SwePub)lud (SwePub)uud (SwePub)kid (SwePub)liu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Baumann, Piau Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden4 aut |
245 | 1 0 | a Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. |
264 | 1 | b Elsevier BV,c 2008 |
520 | a BACKGROUND AND AIMS: In a retrospective study using stereotactic body radiotherapy (SBRT) in medically inoperable patients with stage I NSCLC we previously reported a local control rate of 88% utilizing a median dose of 15Gyx3. This report records the toxicity encountered in a prospective phase II trial, and its relation to coexisting chronic obstructive pulmonary disease (COPD) and cardio vascular disease (CVD). MATERIAL AND METHODS: Sixty patients were entered in the study between August 2003 and September 2005. Fifty-seven patients (T1 65%, T2 35%) with a median age of 75 years (59-87 years) were evaluable. The baseline mean FEV1% was 64% and median Karnofsky index was 80. A total dose of 45Gy was delivered in three fractions at the 67% isodose of the PTV. Clinical, pulmonary and radiological evaluations were made at 6 weeks, 3, 6, 9, 12, 18, and 36 months post-SBRT. Toxicity was graded according to CTC v2.0 and performance status was graded according to the Karnofsky scale. RESULTS: At a median follow-up of 23 months, 2 patients had relapsed locally. No grade 4 or 5 toxicity was reported. Grade 3 toxicity was seen in 12 patients (21%). There was no significant decline of FEV1% during follow-up. Low grade pneumonitis developed to the same extent in the CVD 3/17 (18%) and COPD 7/40 (18%) groups. The incidence of fibrosis was 9/17 (53%) and pleural effusions was 8/17 (47%) in the CVD group compared with 13/40 (33%) and 5/40 (13%) in the COPD group. CONCLUSION: SBRT for stage I NSCLC patients who are medically inoperable because of COPD and CVD results in a favourable local control rate with a low incidence of grade 3 and no grade 4 or 5 toxicity. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Radiologi och bildbehandling0 (SwePub)302082 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Radiology, Nuclear Medicine and Medical Imaging0 (SwePub)302082 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng |
653 | a Aged | |
653 | a Aged | |
653 | a 80 and over | |
653 | a Carcinoma | |
653 | a Non-Small-Cell Lung | |
653 | a pathology | |
653 | a physiopathology | |
653 | a radiotherapy | |
653 | a Cardiovascular Diseases | |
653 | a complications | |
653 | a Chi-Square Distribution | |
653 | a Dose Fractionation | |
653 | a Female | |
653 | a Humans | |
653 | a Lung Neoplasms | |
653 | a pathology | |
653 | a physiopathology | |
653 | a radiotherapy | |
653 | a Male | |
653 | a Middle Aged | |
653 | a Neoplasm Staging | |
653 | a Prospective Studies | |
653 | a Pulmonary Disease | |
653 | a Chronic Obstructive | |
653 | a complications | |
653 | a Radiosurgery | |
653 | a methods | |
653 | a Radiotherapy Dosage | |
653 | a Respiratory Function Tests | |
653 | a Retrospective Studies | |
653 | a Treatment Outcome | |
653 | a COPD | |
653 | a SBRT | |
653 | a Inoperable stage I NSCLC | |
653 | a CVD | |
653 | a MEDICINE | |
700 | 1 | a Nyman, Jan,d 1956u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences,Department of Oncology and Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden4 aut0 (Swepub:gu)xnymja |
700 | 1 | a Hoyer, Mortenu Divisions of Oncology and Medical Physics, Aarhus University Hospital, Denmark4 aut |
700 | 1 | a Gagliardi, Giovannau Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden4 aut |
700 | 1 | a Lax, Ingmaru Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden4 aut |
700 | 1 | a Wennberg, Beritu Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden4 aut |
700 | 1 | a Drugge, Ninniu Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences,Department of Oncology and Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden4 aut |
700 | 1 | a Ekberg, Larsu Divisions of Oncology, Hospital Physics, Malmö University Hospital, Sweden4 aut |
700 | 1 | a Friesland, Signeu Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden4 aut |
700 | 1 | a Johansson, Karl-Axelu Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences,Department of Oncology and Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden4 aut |
700 | 1 | a Lund, Jo-Smund4 aut |
700 | 1 | a Morhed, Elisabethu Department of Oncology and Radiotherapy, Akademiska University Hospital, Uppsala, Sweden4 aut |
700 | 1 | a Nilsson, Kristinau Uppsala universitet,Enheten för onkologi,Department of Oncology and Radiotherapy, Akademiska University Hospital, Uppsala, Sweden4 aut0 (Swepub:uu)kristnil |
700 | 1 | a Levin, Ninau Department of Oncology, Trondheim University Hospital, Norway4 aut |
700 | 1 | a Paludan, Mereteu Divisions of Oncology and Medical Physics, Aarhus University Hospital, Denmark4 aut |
700 | 1 | a Sederholm, Christeru Östergötlands Läns Landsting,Linköpings universitet,Hälsouniversitetet,Lungmedicin,Lungmedicinska kliniken US4 aut0 (Swepub:liu)chrse81 |
700 | 1 | a Traberg, Andersu Divisions of Oncology and Medical Physics, Aarhus University Hospital, Denmark4 aut |
700 | 1 | a Wittgren, Lenau Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine,Divisions of Oncology, Hospital Physics, Malmö University Hospital, Sweden4 aut0 (Swepub:lu)rfa-lwi |
700 | 1 | a Lewensohn, Rolfu Karolinska Institutet,Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden4 aut |
700 | 1 | a Lund, JAu Lund, J.-Å., Department of Oncology, Trondheim University Hospital, Norway4 aut |
710 | 2 | a Karolinska Institutetb Divisions of Oncology, Hospital Physics, Radiumhemment, Sweden4 org |
773 | 0 | t Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncologyd : Elsevier BVg 88:3, s. 359-67q 88:3<359-67x 0167-8140x 1879-0887 |
856 | 4 | u http://dx.doi.org/10.1016/j.radonc.2008.07.019y FULLTEXT |
856 | 4 8 | u https://gup.ub.gu.se/publication/100357 |
856 | 4 8 | u https://doi.org/10.1016/j.radonc.2008.07.019 |
856 | 4 8 | u https://lup.lub.lu.se/record/1284130 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-105474 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:117783253 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-50265 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy